Natco Pharma rose 1.00% to Rs 1,409.70 after the company’s consolidated net profit surged 83.55% to Rs 677.30 crore in Q2 FY25 as against Rs 369 crore reported in Q2 FY24.
Posts in category All News
Hyundai Motor slides as Q2 PAT slips 16% YoY to Rs 1,375 cr (12-11-2024)
Hyundai Motor India declined 2.05% to Rs 1,785 after the car maker’s consolidated net profit decreased 15.54% to Rs 1,375.47 crore on 7.5% slide in revenue from operations to Rs 17,260.38 crore in Q2 FY25 over Q2 FY24.
Shilpa Medicare update on its CDMO partner – Unicycive Therapeutics (12-11-2024)
USFDA accepts Unicycive Therapeutics’ NDA for Oxylanthanum Carbonate
Asian Paints down for 4th straight day; plunges 11% in 2 days on weak Q2 (12-11-2024)
Analyst at Elara Capital said it anticipate further market share erosion for Asian Paints and believe investors should not catch a falling knife as the industry is going through structural change.
Supreme Industries stock sinks on weak Q2 show (12-11-2024)
The stock of the country’s largest plastic pipe maker Supreme Industries has shed 22 per cent since its highs in October. The September quarter results were below expectations as the volatility in polyvinyl chloride (PVC) resin prices led to a major destocking across the trade channel.
Alembic Pharmaceuticals receives USFDA approval for Ivabradine Tablets (12-11-2024)
Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ivabradine Tablets, 5 mg and 7.5 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Corlanor Tablets, 5 mg and 7.5 mg, of Amgen Inc. (Amgen).
NTPC Green seeks $12 bn valuation in one of biggest renewable industry IPO (12-11-2024)
NTPC Green’s IPO would follow the successful listing of Waaree Energies Ltd., which raised $514 million last month and was subscribed more than 70 times
Hyundai Motor India shares drop 3% on weak Q2 numbers; profit tanks 16% YoY (12-11-2024)
The fall in Hyundai Motor India’s stock price follows its announcement of financial results for the second quarter of the FY25, which is also its maiden quarterly earnings since its market debut
Rajeesh’s Portfolio (12-11-2024)
Bought 3 shares Tata motors at 784!!!
And officially my Portfolio entered into Red zone after holding the FII onslaught for Oct & Nov till date.